BioNTech SE (FRA:22UA)
Germany · Delayed Price · Currency is EUR 79.70
+0.75 (0.95%)
At close: Jul 17, 2026
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of €20.22 billion as of July 17, 2026. Its market cap has decreased by -14.79% in one year.
Market Cap
20.22B
Enterprise Value
6.71B
Revenue
2.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
€79.70
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from 2.72B to 20.22B, an increase of 643.08%. That is a compound annual growth rate of 34.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 20.22B | 3.69% |
| Dec 31, 2025 | 19.50B | -26.11% |
| Dec 31, 2024 | 26.39B | 16.25% |
| Dec 29, 2023 | 22.70B | -33.55% |
| Dec 30, 2022 | 34.16B | -37.61% |
| Dec 31, 2021 | 54.75B | 241.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 60.91B |
| Bayer Aktiengesellschaft | 46.87B |
| Siemens Healthineers AG | 38.76B |
| Fresenius SE & Co. KGaA | 23.53B |
| Sartorius Aktiengesellschaft | 15.42B |
| Fresenius Medical Care AG | 11.19B |
| Ottobock SE & Co. KGaA | 3.44B |
| Fielmann Group AG | 3.31B |